• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Quantifying homologous and heterologous antibody titre rises after influenza virus infection

tetano

Editor, Senior Moderator
Epidemiol Infect. 2016 Mar 28:1-11. [Epub ahead of print]
[h=1]Quantifying homologous and heterologous antibody titre rises after influenza virus infection.[/h] Freeman G[SUP]1[/SUP], Perera RA[SUP]1[/SUP], Ngan E[SUP]1[/SUP], Fang VJ[SUP]1[/SUP], Cauchemez S[SUP]2[/SUP], Ip DK[SUP]1[/SUP], Peiris JS[SUP]1[/SUP], Cowling BJ[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Most influenza virus infections are associated with mild disease. One approach to estimate the occurrence of influenza virus infections in individuals is via repeated measurement of humoral antibody titres. We used baseline and convalescent antibody titres measured by haemagglutination inhibition (HI) and viral neutralization (VN) assays against influenza A(H1N1), A(H3N2) and B viruses to investigate the characteristics of antibody rises following virologically confirmed influenza virus infections in participants in a community-based study. Multivariate models were fitted in a Bayesian framework to characterize the distribution of changes in antibody titres following influenza A virus infections. In 122 participants with PCR-confirmed influenza A virus infection, homologous antibody titres rose by geometric means of 1?2- to 10?2-fold after infection with A(H1N1), A(H3N2) and A(H1N1)pdm09. Significant cross-reactions were observed between A(H1N1)pdm09 and seasonal A(H1N1). Antibody titre rises for some subtypes and assays varied by age, receipt of oseltamivir treatment, and recent receipt of influenza vaccination. In conclusion, we provided a quantitative description of the mean and variation in rises in influenza virus antibody titres following influenza virus infection. The multivariate patterns in boosting of antibody titres following influenza virus infection could be taken into account to improve estimates of cumulative incidence of infection in seroepidemiological studies.


[h=4]KEYWORDS:[/h] Antibody; epidemiology; influenza; serology

PMID: 27018720 [PubMed - as supplied by publisher]
 
Back
Top Bottom